Annual Drug Patent Expirations for SLYND
Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. There are nine patents protecting this drug.
This drug has forty-eight patent family members in twenty-eight countries.
The generic ingredient in SLYND is drospirenone. Additional details are available on the drospirenone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
